vs
Side-by-side financial comparison of JBG SMITH Properties (JBGS) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
JBG SMITH Properties is the larger business by last-quarter revenue ($127.6M vs $76.2M, roughly 1.7× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -35.7%, a 43.1% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -2.5%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -6.3%).
JBG SMITH PropertiesJBGSEarnings & Financial Report
JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
JBGS vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $127.6M | $76.2M |
| Net Profit | $-45.5M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | -47.5% | 11.0% |
| Net Margin | -35.7% | 7.4% |
| Revenue YoY | -2.5% | 25.5% |
| Net Profit YoY | 24.0% | 30.7% |
| EPS (diluted) | $-0.76 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $127.6M | $76.2M | ||
| Q3 25 | $123.9M | $71.9M | ||
| Q2 25 | $126.5M | $63.1M | ||
| Q1 25 | $120.7M | $59.1M | ||
| Q4 24 | $130.8M | $60.7M | ||
| Q3 24 | $136.0M | $58.0M | ||
| Q2 24 | $135.3M | $55.0M | ||
| Q1 24 | $145.2M | $50.6M |
| Q4 25 | $-45.5M | $5.6M | ||
| Q3 25 | $-28.6M | $3.5M | ||
| Q2 25 | $-19.2M | $3.2M | ||
| Q1 25 | $-45.7M | $2.6M | ||
| Q4 24 | $-59.9M | $4.3M | ||
| Q3 24 | $-27.0M | $3.9M | ||
| Q2 24 | $-24.4M | $1.5M | ||
| Q1 24 | $-32.3M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | -47.5% | 11.0% | ||
| Q3 25 | -27.5% | 7.8% | ||
| Q2 25 | -18.4% | 8.1% | ||
| Q1 25 | -44.7% | 6.5% | ||
| Q4 24 | -53.6% | 10.6% | ||
| Q3 24 | -22.4% | 9.7% | ||
| Q2 24 | -24.3% | 6.6% | ||
| Q1 24 | -30.1% | 4.4% |
| Q4 25 | -35.7% | 7.4% | ||
| Q3 25 | -23.1% | 4.9% | ||
| Q2 25 | -15.2% | 5.0% | ||
| Q1 25 | -37.9% | 4.4% | ||
| Q4 24 | -45.8% | 7.1% | ||
| Q3 24 | -19.8% | 6.7% | ||
| Q2 24 | -18.0% | 2.7% | ||
| Q1 24 | -22.2% | 3.2% |
| Q4 25 | $-0.76 | $0.14 | ||
| Q3 25 | $-0.48 | $0.09 | ||
| Q2 25 | $-0.29 | $0.08 | ||
| Q1 25 | $-0.56 | $0.06 | ||
| Q4 24 | $-0.70 | $0.10 | ||
| Q3 24 | $-0.32 | $0.10 | ||
| Q2 24 | $-0.27 | $0.04 | ||
| Q1 24 | $-0.36 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $75.3M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $141.5M |
| Total Assets | $4.4B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.3M | $13.5M | ||
| Q3 25 | $64.4M | $11.1M | ||
| Q2 25 | $61.4M | $20.0M | ||
| Q1 25 | $81.3M | $10.2M | ||
| Q4 24 | $145.8M | $17.5M | ||
| Q3 24 | $137.0M | $11.3M | ||
| Q2 24 | $163.5M | $8.8M | ||
| Q1 24 | $220.5M | $7.3M |
| Q4 25 | $1.2B | $141.5M | ||
| Q3 25 | $1.2B | $133.6M | ||
| Q2 25 | $1.3B | $139.7M | ||
| Q1 25 | $1.6B | $134.8M | ||
| Q4 24 | $1.8B | $131.4M | ||
| Q3 24 | $1.9B | $125.0M | ||
| Q2 24 | $2.0B | $119.4M | ||
| Q1 24 | $2.1B | $116.3M |
| Q4 25 | $4.4B | $199.2M | ||
| Q3 25 | $4.4B | $202.4M | ||
| Q2 25 | $4.5B | $184.6M | ||
| Q1 25 | $4.7B | $178.1M | ||
| Q4 24 | $5.0B | $177.1M | ||
| Q3 24 | $5.2B | $169.5M | ||
| Q2 24 | $5.3B | $163.9M | ||
| Q1 24 | $5.4B | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.3M | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.3M | $18.4M | ||
| Q3 25 | $8.9M | $18.4M | ||
| Q2 25 | $18.8M | $12.3M | ||
| Q1 25 | $12.9M | $2.9M | ||
| Q4 24 | $129.4M | $15.0M | ||
| Q3 24 | $26.4M | $12.7M | ||
| Q2 24 | $23.8M | $10.2M | ||
| Q1 24 | $37.0M | $1.2M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-12.6M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -9.5% |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 19.0% | ||
| Q2 24 | — | 16.3% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
